Science Explorer Interactive view Map
Company · Cambridge · United States

Akebia Therapeutics (United States)

akebia.comROR OpenAlex
World rank, all time
#32,557
of 42,892
Rank in United States
#6,935
of 8,685
Research works
135
▲ 553% vs 2013–17
Citations
2.3k
16.9 per fractional work
Top-10% rate
13.6%
record average 16.5%
Open access
33%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 3.70× its world share, 8 worksBiochemistry, Geneti…Immunology and Microbiology: 8.03× its world share, 3 worksImmunology and Micro…Neuroscience: 1.15× its world share, 1 worksNeuroscienceChemistry: 0.93× its world share, 1 worksChemistryComputer Science: 0.04× its world share, 0 worksComputer ScienceEngineering: 0.02× its world share, 0 worksEngineeringEnvironmental Science: 0.01× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.08× its world share, 0 worksMaterials ScienceHealth Professions: 0.14× its world share, 0 worksHealth ProfessionsMedicine: 3.40× its world share, 25 worksMedicineNursing: 0.60× its world share, 0 worksNursingEconomics, Econometrics and Finance: 0.51× its world share, 0 worksEconomics, Econometr…Psychology: 0.28× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 8.0×. Every wedge is a field page.

Who are the top researchers at Akebia Therapeutics (United States)?

Ranked on the composite score, Nello Mainolfi, Michele Mayo and Kirti Sharma lead among researchers whose main affiliation is Akebia Therapeutics (United States).

  1. 1 Nello Mainolfi United States · #1,417,766 worldwide 56 citations · 21 works
  2. 2 Michele Mayo United States · #1,425,604 worldwide 40 citations · 19 works
  3. 3 Kirti Sharma United States · #1,460,241 worldwide 55 citations · 22 works
All ranked researchers at Akebia Therapeutics (United States)

Which keywords describe research at Akebia Therapeutics (United States)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chronic Kidney Disease, Cardiovascular Disease, Anemia, Cancer Treatment, Heart Failure, Iron Deficiency, Neuroprotection and Erythropoiesis-Stimulating Agents.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chronic Kidney Disease9▲ 104×6 topics
  2. Cardiovascular Disease8▲ 20×5 topics
  3. Anemia7▲ 193×4 topics
  4. Cancer Treatment6▲ 74×3 topics
  5. Heart Failure6▲ 39×4 topics
  6. Iron Deficiency6▲ 326×2 topics
  7. Neuroprotection6▲ 48×2 topics
  8. Erythropoiesis-Stimulating Agents6▲ 1270×1 topic
  9. Hypoxia-Inducible Factors6▲ 1270×1 topic
  10. Inflammation4▲ 4.6×11 topics
  11. Tumor Microenvironment3▲ 20×4 topics
  12. Cancer3▲ 5.6×12 topics
  13. Cancer Immunotherapy2▲ 43×2 topics
  14. Immunotherapy2▲ 7.6×5 topics
  15. Cancer Therapy2▲ 8.8×8 topics
  16. Immunity2▲ 12×4 topics
  17. Quality of Life2▲ 3.6×4 topics
  18. Glycosylation2▲ 39×3 topics
  19. Hemodialysis2▲ 55×2 topics
  20. Lymphoma2▲ 27×2 topics
  21. Mortality2▲ 7.3×3 topics
  22. Nutrition2▲ 9.4×2 topics
  23. Tumor Regression2▲ 38×2 topics
  24. Dialysis2▲ 80×1 topic
  25. Peritoneal Dialysis2▲ 80×1 topic
  26. Immune Checkpoint Blockade1▲ 33×1 topic
  27. Monoclonal Antibodies1▲ 41×2 topics
  28. PD-1 and PD-L11▲ 33×1 topic
  29. Antigen Presentation1▲ 39×2 topics
  30. CAR T Cells1▲ 46×1 topic
  31. Chimeric Antigen Receptor1▲ 46×1 topic
  32. Dendritic Cells1▲ 36×1 topic
  33. Fc Receptors1▲ 59×1 topic
  34. Therapeutic Antibodies1▲ 46×1 topic
  35. Tumor Antigen1▲ 53×1 topic
  36. BRCA Mutation1▲ 130×1 topic
  37. FGF231▲ 86×1 topic
  38. HIF-11▲ 50×1 topic
  39. PARP Inhibitors1▲ 130×1 topic
  40. Warburg Effect1▲ 50×1 topic

Which research topics does Akebia Therapeutics (United States) publish most on?

By volume in 2022–2025: Erythropoietin and Anemia Treatment, Dialysis and Renal Disease Management, Cancer Immunotherapy and Biomarkers and CAR-T cell therapy research.

Erythropoietin and Anemi…6Erythropoietin and Anemia Treatment: 6 fractional worksDialysis and Renal Disease Management: 2 fractional worksCancer Immunotherapy and Biomarkers: 1 fractional worksCAR-T cell therapy research: 1 fractional worksImmunotherapy and Immune Responses: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksCancer, Hypoxia, and Metabolism: 1 fractional worksParathyroid Disorders and Treatments: 1 fractional worksPARP inhibition in cancer therapy: 1 fractional worksImmune Cell Function and Interaction: 1 fractional works
HematologyNephrologyOncologyImmunology2 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Erythropoietin and Anemia Treatment Hematology 6 works
  2. 2 Dialysis and Renal Disease Management Nephrology 2 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 1 works
  4. 4 CAR-T cell therapy research Oncology 1 works
  5. 5 Immunotherapy and Immune Responses Immunology 1 works
  6. 6 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  7. 7 Cancer, Hypoxia, and Metabolism Cancer Research 1 works
  8. 8 Parathyroid Disorders and Treatments Nephrology 1 works
  9. 9 PARP inhibition in cancer therapy Oncology 1 works
  10. 10 Immune Cell Function and Interaction Immunology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available32.7%not open67.3%

World: 28% of research is openly available.

with international co-authors25.0%domestic only75.0%

World: 19% is written across borders.

How has Akebia Therapeutics (United States)'s research output changed?

Output in 2018–2022 was 553% higher than in 2013–2017.

200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Cambridge

All research institutions in Cambridge

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.